Massachusetts 2023-2024 Regular Session

Massachusetts Senate Bill S1418

Introduced
2/16/23  
Refer
2/16/23  

Caption

To restore integrity in the marketing of pharmaceutical products and medical devices

Companion Bills

MA S2733

Replaced by Order relative to authorizing the joint committee on Health Care Financing to make an investigation and study of certain current Senate documents relative to health care financing.

Previously Filed As

MA S1583

To restore integrity in the marketing of pharmaceutical products and medical devices

MA HB07179

An Act Concerning Pharmaceutical Marketing And Pharmaceuticals.

MA AB1419

Medical waste: pharmaceuticals.

MA SB00270

An Act Concerning The Prohibition Of Certain Gifts From Pharmaceutical And Medical Device Manufacturing Companies To Health Care Providers.

MA S783

To promote transparency and prevent price gouging of pharmaceutical drug prices

MA S2492

Relative to pharmaceutical access, costs and transparency

MA S2035

To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

MA S1862

To eliminate the tax deduction for direct-to-consumer pharmaceutical marketing

MA S895

To promote transparency and prevent price gouging of pharmaceutical drug prices

MA S0482

Amends the types of products which pharmacists may prescribe as substitute drugs or products to include "devices and supplies" and "therapeutically equivalent drugs and pharmaceuticals".

Similar Bills

CA AB2445

Prescriptions: personal use pharmaceutical disposal system.

AR HB1301

To Amend The Prior Authorization Transparency Act.

CA SB642

Pharmacy benefit management: Prescription Acquisition and Adjudication Agency.

CA AB265

Prescription drugs: prohibition on price discount.

CT HB05384

An Act Concerning Prescription Drug Costs.

LA HB384

Creates and provides for a state prescription drug importation program (OR INCREASE SG EX See Note)

CA AB29

Pharmacy benefit managers.

CA SB212

Solid waste: pharmaceutical and sharps waste stewardship.